Research graph
References from Effects of pentoxifylline in patients with chronic Chagas cardiomyopathy: A randomized, double-blind, controlled pilot trial. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Chagas disease
10.1016/s0140-6736(17)31612-4 · 2018 · External reference
Chronic Chagas Heart Disease Management: From Etiology to Cardiomyopathy Treatment
10.1016/j.jacc.2017.08.004 · 2017 · External reference
Chagas disease: an overview of clinical and epidemiological aspects
10.1016/j.jacc.2013.05.046 · 2013 · External reference
Pathogenesis of chronic Chagas heart disease
10.1161/circulationaha.106.624296 · 2007 · External reference
Regional Myocardial Perfusion Disturbance in Experimental Chronic Chagas Cardiomyopathy
10.2967/jnumed.117.205450 · 2018 · External reference
Pathogenesis of chronic Chagas cardiomyopathy: the role of coronary microvascular derangements
10.1590/0037-8682-0028-2013 · 2013 · External reference
Pathogenesis of chronic Chagas heart disease
1999 · External reference
Chagas disease
10.1016/s0140-6736(10)60061-x · 2010 · External reference
Sobre a anatomia patológica da doença de Chagas
10.1590/s0074-02761941000300015 · 1941 · External reference
Microvascular changes as a cause of chronic cardiomyopathy in Chagas’ disease
10.1016/0002-8703(90)90191-y · 1990 · External reference
New concept of the pathogenesis of “Chagas disease” “American trypanosomiasis”: allergic granulomatous inflammation and hyperergic myocarditis produced in “rhesus” inoculated with dead forms of Schizotrypanum cruzi
1947 · External reference
Importance of TNF-alpha in the course of acute infection with Trypanosoma cruzi: influence of its inhibition by pentoxifylline treatment
10.1590/s0074-02762008005000006 · 2008 · External reference
Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process
1993 · External reference
Locally produced survival cytokines IL-15 and IL-7 may be associated to the predominance of CD8+ T cells at heart lesions of human chronic Chagas disease cardiomyopathy
10.1111/j.1365-3083.2007.01987.x · 2007 · External reference
Chronic Chagas’ disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection
10.1006/jaut.2001.0523 · 2001 · External reference
Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/"indeterminate" and Chagas disease cardiomyopathy patients
10.1590/s0074-02762003000300021 · 2003 · External reference
Cytokines, phagocytes, and pentoxifylline
1995 · External reference
The anti-inflammatory effects of the phosphodiesterase inhibitor pentoxifylline in the rat
10.1016/s1043-6618(03)00002-1 · 2003 · External reference
Pentoxifylline reverses chronic experimental Chagasic cardiomyopathy in association with repositioning of abnormal CD8+ T-cell response
10.1371/journal.pntd.0003659 · 2015 · External reference
Pentoxifylline selectivity inhibits tumor necrosis factor synthesis in the arterial wall
1995 · External reference
Tumor necrosis factor in CHF: a double facet cytokine
10.1016/s0008-6363(97)00309-x · 1998 · External reference
Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines
10.1378/chest.105.3.897 · 1994 · External reference
Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy
10.1016/s0140-6736(97)09338-0 · 1998 · External reference
Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study
10.1161/01.cir.103.8.1083 · 2001 · External reference
Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated congestive heart failure secondary to idiopathic dilated cardiomyopathy
10.1016/s0002-9149(02)02779-0 · 2002 · External reference
Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays
10.1186/1471-2172-10-52 · 2009 · External reference
Validation of echocardiographic methods for assessing left ventricular dysfunction in rats with myocardial infarction
10.1152/ajpheart.00393.2004 · 2004 · External reference
ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers
10.1007/s12350-015-0387-x · 2016 · External reference
Validation of the Brazilian version of the generic six-dimensional short form quality of life questionnaire (SF-6D Brazil)
10.1590/s1413-81232011000800010 · 2011 · External reference
Changes in myocardial perfusion correlate with deterioration of left ventricular systolic function in chronic Chagas’ cardiomyopathy
10.1016/j.jcmg.2008.09.012 · 2009 · External reference
Chagas cardiomyopathy: prognosis in clinical and hemodynamic profile C
2010 · External reference
Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association
2018 · External reference
Effects of pentoxifylline on inflammatory markers and blood pressure: a systematic review and meta-analysis of randomized controlled trials
10.1097/hjh.0000000000001086 · 2016 · External reference
Pentoxifylline in ischemic, hypertensive and idiopathic-dilated cardiomyopathy: effects on left-ventricular function, inflammatory cytokines and symptoms
10.1016/j.ejheart.2003.09.005 · 2004 · External reference
Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review
10.1373/clinchem.2006.075713 · 2007 · External reference
Cardiovascular biomarkers as predictors of adverse outcomes in chronic Chagas cardiomyopathy
10.1371/journal.pone.0258622 · 2021 · External reference
Biomarkers in Trypanosoma cruzi-infected and uninfected individuals with varying severity of cardiomyopathy in Santa Cruz, Bolivia
10.1371/journal.pntd.0003227 · 2014 · External reference
Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease
10.1016/j.ijcard.2015.07.040 · 2015 · External reference
Echocardiography in Chagas heart disease
10.1161/circulationaha.106.627323 · 2007 · External reference
Pentoxifylline reduces inflammation and prevents myocardial perfusion derangements in experimental chronic Chagas’ cardiomyopathy
10.1007/s12350-023-03270-y · 2023 · External reference
TNF blockade aggravates experimental chronic Chagas disease cardiomyopathy
10.1016/j.micinf.2007.05.014 · 2007 · External reference
Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: results of a randomized study
10.1161/01.cir.0000112568.48837.60 · 2004 · External reference
The prognostic value of the electrocardiographic features of chronic Chagas’ disease
1968 · External reference
Fibrilação atrial na cardiopatia chagásica crônica
1994 · External reference
Development and validation of a risk score for predicting death in Chagas’ heart disease
10.1056/nejmoa053241 · 2006 · External reference
Prognostic value of QT interval parameters for mortality risk stratification in Chagas’ disease: results of a long-term follow-up study
10.1161/01.cir.0000079174.13444.9c · 2003 · External reference
QT dispersion: an indication of arrhythmia risk in patients with long QT intervals
10.1136/hrt.63.6.342 · 1990 · External reference
ECG scar quantification correlates with cardiac magnetic resonance scar size and prognostic factors in Chagas’ disease
10.1136/hrt.2010.210047 · 2011 · External reference
Effects of Pentoxifylline on Exercising Skeletal Muscle Vascular Control in Rats with Chronic Heart Failure
10.12970/2311-052x.2014.02.01.7 · 2014 · External reference
Hemorheological effects of pentoxifylline on disturbed flow behavior of blood in patients with cerebrovascular insufficiency
10.1159/000115658 · 1983 · External reference
Leukocyte activation study during occlusive arterial disease of the lower limb: effect of pentoxifylline infusion
1995 · External reference
Effect of ingested pentoxifylline on neutrophil superoxide anion production
10.1128/iai.60.11.4504-4509.1992 · 1992 · External reference
